Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Intellipharmaceutics International Inc. (V.IPC) had Normalized Income after Taxes of -2.52M for the most recently reported fiscal quarter, ending 2023-08-31.
| Income Statement Financials | |
-- |
|
-2.52M |
|
-- |
|
-- |
|
-- |
|
-2.38M |
|
-- |
|
-2.52M |
|
-2.52M |
|
-2.52M |
|
-2.52M |
|
-2.52M |
|
|
Normalized Income after Taxes |
-2.52M |
-2.38M |
|
-2.33M |
|
33.09M |
|
33.09M |
|
-0.08 |
|
-0.08 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
2.09M |
|
-- |
|
-- |
|
-- |
|
19.26M |
|
-17.17M |
|
-17.17M |
|
-17.17M |
|
33.09M |
|
| Cash Flow Statement Financials | |
0.42M |
|
-- |
|
-- |
|
0.11M |
|
0.53M |
|
0.42M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.06 |
|
-- |
|
-- |
|
-- |
|
-0.17 |
|
-1171.45% |
|
-2601.02% |
|
-2601.02% |
|
-- |
|
-2749.25% |
|
-2749.25% |
|
0.42M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
0.26 |
|
351.23 |
|
14.67% |
|
14.67% |
|
-120.65% |
|
14.67% |
|
-0.52 |
|
0.01 |
|
0.01 |
|